Sign in

CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Aura Biosciences, Inc.

Sign in to watch
Ticker
AURA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320271970
Phone
(617)500-8864
Business address
80 GUEST STREET, BOSTON, MA, 02135
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-11-02 de los Pinos Elisabet See Remarks Conversion +4,552 131,412
2021-11-02 de los Pinos Elisabet See Remarks Conversion · Series A-1 Preferred Stock −3,042 0
2021-11-02 de los Pinos Elisabet See Remarks Conversion · Series A-2 Preferred Stock −1,510 0
2021-11-02 Johnson David Michael Director Conversion +139,672 139,672
2021-11-02 Johnson David Michael Director Conversion · Series E Convertible Preferred Stock −139,672 0
2021-10-28 Johnson David Michael Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2021-10-28 Rich Cadmus See Remarks Grant or award +26,250 26,250
2021-10-28 Rich Cadmus See Remarks Grant or award · Stock Option (Right to Buy) +112,500 112,500
2021-10-28 de los Pinos Elisabet See Remarks Grant or award +74,357 74,357
2021-10-28 de los Pinos Elisabet See Remarks Grant or award · Stock Option (Right to Buy) +318,750 318,750
2021-10-28 De Rosch Mark Chief Operating Officer Grant or award +17,500 17,500
2021-10-28 De Rosch Mark Chief Operating Officer Grant or award · Stock Option (Right to Buy) +75,000 75,000
2021-10-28 Mattessich Antony C. Director Grant or award · Stock Option (Right to Buy) +16,000 16,000
2021-10-28 Feder Julie B Chief Financial Officer Grant or award +26,250 26,250
2021-10-28 Feder Julie B Chief Financial Officer Grant or award · Stock Option (Right to Buy) +112,500 112,500
2021-10-28 PAREKH RAJESH B Director Grant or award · Stock Option (Right to Buy) +16,000 16,000
2021-10-28 Primiano Christopher Brett Chief Business Officer Grant or award +8,750 8,750
2021-10-28 Primiano Christopher Brett Chief Business Officer Grant or award · Stock Option (Right to Buy) +37,500 37,500
2021-10-28 Srivastava Sapna Director Grant or award · Stock Option (Right to Buy) +16,000 16,000

Page 11 of 11 · 219 trades